By Sam Boykin
CHARLOTTE — With resources like the N.C. Research Campus, a major university, an international airport and an active community of business leaders and entrepreneurs, Charlotte is well poised to tap into the growing biotechnology industry. But according to Simon Pedder, it also lacks key ingredients like a research-based medical facility and a reliable funding source for start-up biotech companies.
Pedder, CEO and founder of Chelsea Therapeutics International Inc., a Charlotte biopharmaceutical development company, spoke at last week’s Eighth Annual Charlotte Biotechnology Conference at UNC Charlotte.
Enter your email address/USER ID and password in the fields above to gain access to the subscriber content on this site.
Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time. To inquire about group subscriptions for your organization, contact Joann Griffin.
Already a paid subscriber but not registered for online access yet? Click Here to register.
Forgot password or User ID?